Key result
Acute myocardial infarction triggers two-wave release of angiogenic factors, peaking at ~24 and ~170 hours.
Observational (n=44)
Answers are grounded in this paper and cite their sources.
Demonstrates a biphasic release of angiogenic growth factors in acute myocardial infarction patients, suggesting distinct roles in acute response and tissue repair.
BACKGROUND: Previous studies have shown that angiopoietic growth factors, including vascular endothelial growth factor (VEGF), angiopoietin-2 (Ang-2), hepatocyte growth factor (HGF) and transforming growth factor (TGF)-beta1 are released after acute myocardial infarction (AMI). It was suggested that the release of these factors, triggered by ischemia, may be related to a reparative neoangiogenetic process. METHODS: Plasma VEGF, Ang-2, HGF and TGF-beta levels were measured on admission (baseline) and at various times during the acute (0-48 h) and the subacute (48-240 h) phase in 44 patients with AMI. RESULTS: In the present study, we have explored in detail the kinetics of release of these growth factors after AMI with the precise aim of evaluating the existence of a double wave of release of these factors: (i) a first wave in the acute and (ii) a second one in the subacute period. The results of these analyses provided evidence for an early (peak at 24-28 h) and late (peak at approximately 170 h) increase of VEGF, Ang-2 and TGF-beta. CONCLUSIONS: According to these data, we suggest that two waves of release of angiogenic factors occur after AMI. The early release makes part of an acute phase response, whereas the late release may underlie the induction of angiogenetic mechanisms involved in tissue reparation.
No takes yet. Share an insight, caveat, or question.
Pannitteri et al. (2006) conducted an observational in Acute myocardial infarction (AMI) (n=44). Acute myocardial infarction (ischemia) vs. Baseline (admission levels) was evaluated on Kinetics of plasma VEGF, Ang-2, HGF, and TGF-beta levels. Acute myocardial infarction triggered a two-wave release of plasma VEGF, Ang-2, and TGF-beta, peaking early at 24-28 hours and late at approximately 170 hours.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: